CS Paper Radar

pCoMole: Pareto-Constrained Molecule Editing with Discrete Flows

Tong Chen, Maximilian Holsman, Lin Zhao, Pranam Chatterjee

cs.LG q-bio.BM ·submitted 2026-10-01 13:24 UTC · v2
top venue

Abstract

Biomolecular therapeutics often start from known sequences and require targeted editing to improve multiple properties while satisfying hard biochemical and manufacturability constraints. However, existing generative methods do not jointly support multi-objective optimization, hard feasibility, and sequence editing in discrete, variable-length biological spaces. In this work, we introduce Pareto-Constrained Molecule Editing (pCoMole), a framework built on discrete flow matching that steers a pre-trained Edit Flow toward user-specified preferences while enforcing terminal feasibility. pCoMole defines a feasibility-gated terminal distribution using an augmented Tchebycheff utility and realizes the resulting preference tilt through a Doob-h transform of the underlying edit process. To make this construction practical, we approximate the required harmonic function using short Monte Carlo rollouts over candidate edits, yielding an efficient guided editor with provable preference consistency. We validate pCoMole by shrinking GFP while retaining fluorescence-related properties, shortening diverse Cas9 orthologs while preserving PAM specificity, and compressing peptide binders into short peptidomimetics that optimize seven drug-related properties under hard constraints. In wet lab testing, two 229-residue pCoMole-designed eGFP variants retained clear green fluorescence in BL21 cells after 10 deletions, with either one or two substitutions. Together, pCoMole enables constraint-aware, Pareto-aligned editing of biomolecular sequences in discrete, variable-length spaces.

Comment
Published at NeurIPS 2026. (Proceedings of the 40th Conference on Neural Information Processing Systems, Sydney, Australia)

Closest papers

Nearest neighbours by meaning across the whole index.

Navigating Route Latent Space for Synthesizable Molecular Design

cs.AI cs.CE ·2026-10-06 ·Tao Li, Tuan Vinh, Monika Raj, Yuan Fang, Zhichun Guo +1 more
position similarity 0.71
Abstract

Goal-directed molecular design has advanced rapidly, yet a substantial proportion of designed molecules remain difficult to synthesize in practice, limiting their real-world utility. Prior synthesizability-aware methods either project generated molecules back to synthesizable analogs that deviate from the intended target, or optimize directly in discrete synthesis spaces that lack a continuous landscape for efficient search. We argue that this limitation mainly comes from the search space rather than the optimizer. To address this, we propose RouteFlow, a framework that reformulates synthesizable molecular design as a search over a continuous route latent space, where each latent maps back to a complete synthesis route and synthesizability is inherently preserved. To navigate this space, we adopt reward-guided flow matching as an efficient sampler that steers toward high-property regions. Since reward optimization may push latents off the manifold of real synthesis routes, where decoding becomes unreliable, we further introduce a cycle-consistency mechanism to stabilize fine-tuning. Across 16 optimization tasks from Therapeutic Data Commons, RouteFlow achieves the best sample efficiency among synthesizability-aware baselines, with the best synthetic accessibility and the highest retrosynthesis success rate. Our results also confirm that the proposed cycle-consistency reliably keeps optimization on-manifold while improving target properties, supporting effective synthesizable molecular discovery.

0.17

ReMedI: Inference-Time Refinement and Self-Distillation for Controllable Molecular Optimization

cs.LG cs.AI ·2026-10-23 ·Jia Yi Zhang, Shivanshu Shekhar, Allison McLevige, Tong Zhang
position similarity 0.70
Abstract

In drug development, lead optimization must improve competing properties, such as increasing permeability and reducing toxicity, while limiting scaffold changes that could compromise the lead's potency. RL-based post-training, such as C-MORAL, addresses this problem by fine-tuning molecular language models to directly optimize molecular leads for objectives of interest, which relies on expensive task-specific datasets and faces challenges in achieving multi-objective optimization (MOO). We argue a pre-trained model may already contain useful molecular edits that zero-shot generation cannot efficiently reach. Motivated by the limited search capabilities of zero-shot generation, we develop an efficient Metropolis-Hastings search strategy to better explore the proposal distribution. We propose ReMedI, which uses the molecular language model as a base proposer for inference-time alignment. Given a lead and a set of multi-objective tasks, the model proposes edits conditioned on the current molecule, while Metropolis--Hastings refinement guides sequential edits under an objective for property improvement, preservation, and lead similarity. On both C-MuMOInstruct and SMDD benchmarks, refinement improves frozen base models across three backbones, reaching significantly higher multi-objective optimization success rates compared to baselines. These search traces can then distilled into the base model which improves zero-shot generation and subsequent search using approximately 7.8 times less training molecular leads than that of C-MORAL. ReMedI achieves approximately 2.8 times the strict-success coverage of RL baseline C-MORAL, including on out-of-distribution tasks, with matched lead-relative similarity.

0.05

One Sequence, Many Decodings: CAGenMol-2 Recasts Drug Design as Masked Molecular Inference

cs.LG cs.AI ·2026-09-28 ·Yanting Li, Enyan Dai, Lei Wang, Wen-Cai Ye, Li Liu
similarity 0.69
Abstract

Drug design couples property evaluation, conditional generation, structure-based design, and local optimization, yet machine learning systems typically address these capabilities with separate task-specific models. We introduce CAGenMol-2, a masked diffusion molecular language model that represents molecules, continuous scalar properties, and 3D protein pockets within a single wrapped sequence. Within this pretrained interface, downstream operations are selected by which sequence regions are observed or masked at inference, allowing one checkpoint to perform property prediction, property- and pocket-conditioned generation, and partial-constraint design without task-specific architectures or backbone fine-tuning. We further propose Adaptive Fragment Optimization (AdaFO), a gradient-free mask-and-refill search that turns the masked decoder into an iterative local molecular optimizer. On CrossDocked2020, AdaFO increases Success Rate from 30.2\% to 70.8\%, the best reported under this protocol, while largely preserving drug-likeness and diversity. Finally, scaffold-preserving directional editing and CRBN/VHL case studies demonstrate its use in compound design workflows spanning local molecular editing, structure-based prioritization, and downstream simulation-based screening.

0.15

Controllable Molecule Generation via Sparse Representation Editing: An Interpretability-Driven Perspective

cs.LG ·2026-11-06 ·Zhuoran Li, Xu Sun, Chang Wen Chen, Wanyu Lin
code/data similarity 0.68
Abstract

Controllable molecule generation is crucial for diverse scientific applications, such as drug discovery and materials design. While large language models (LLMs) show great promise, their dense and entangled representations impede precise control over the generation of molecules with bespoke substructures or properties. To address this, we propose Sparse Representation Editing (SpaRE), an interpretability-driven framework for fine-grained and precise control in LLM-based molecule generation. The crux of SpaRE is to learn an overcomplete sparse feature space that disentangles LLM representations into a compact set of latent features corresponding to chemically meaningful concepts. Within this space, we can directly manipulate these concept-aligned latent features to achieve (1) local control, by generating target atoms and functional groups at specified positions; and (2) global control, by customizing the overall structural and physicochemical properties within defined ranges. In this way, our framework advances interpretability from post-hoc analysis to actionable generative control. Experiments show that SpaRE can generate chemically desirable molecules under complex constraints in real-world scenarios, while offering mechanistic insights for quantitative structure-property analysis. The code and demo are available at https://github.com/WanyuGroup/ICML2026_SpaRE.

0.38

CupOFMoCA: Coupled Objective-Guided Discrete Flows for Molecular Conjugate Assembly

cs.LG q-bio.BM ·2026-11-11 ·Ruoxi Rosie Zhang, Ziang Li, Jiatao Gu, Pranam Chatterjee
top venue similarity 0.66
Abstract · Published at NeurIPS 2026. (Proceedings of the 40th Conference on Neural Information Processing Systems, Sydney, Australia)

Molecular conjugates, including PROTACs and peptide-drug conjugates (PDCs), derive their function from the joint behavior of multiple coupled components, yet most generative approaches design these components independently and combine them only after generation. Such staged pipelines ignore cross-component dependencies and often produce conjugates that are chemically invalid, fall outside empirical conjugate distributions, or lose function upon assembly. In this work, we introduce Coupled Objective-Guided Discrete Flows for Molecular Conjugate Assembly (CupOFMoCA), a discrete generative method that enforces cross-component chemical constraints during conjugate generation. CupOFMoCA restricts guided updates to chemically feasible conjugate states and reweights local transitions using molecular design objectives. Across three PDC systems, coupled generation achieved 100% conjugation validity among valid peptides and increased valid yield over matched post-hoc filtering, with comparable predicted binding scores across the full valid sets. In three-seed evaluations of three PROTAC systems, CupOFMoCA achieved the highest assembly validity on two systems and generated more assembly-valid molecules per second than the evaluated baselines. We further evaluated the generated PROTACs with post-hoc DegradeMaster scoring and explicit-solvent molecular dynamics, supporting their predicted activity and conformational properties. Together, these results establish CupOFMoCA as an efficient generator of molecular conjugates, supporting therapeutic development via coordinated control of assembly and molecular properties.

0.36

Multi-Objective Generative Optimization via Expected Hypervolume Fine-Tuning

cs.LG ·2026-11-03 ·Juan Guevara, Riccardo De Santi, Andreas Krause, Raul Astudillo
similarity 0.65
Abstract

Scientific discovery requires plausible designs spanning useful trade-offs among competing properties: a molecule with strong binding affinity, for example, may be difficult to synthesize. Pretrained generative models, e.g., flow and diffusion generators, provide a foundation for proposing such designs, but steering them toward high-quality, complementary trade-offs remains challenging. Inference-time search incurs high per-sample costs, while fine-tuning typically relies on fixed per-candidate rewards that do not capture how designs complement one another. We introduce Hypervolume Fine-Tuning (HVFT), which adapts a single pretrained generator to maximize the expected hypervolume of its samples while controlling departure from the pretrained distribution. Expected hypervolume jointly rewards candidate quality and collective trade-off coverage. Nonetheless, we show that it cannot be expressed as the expectation of a fixed per-candidate reward and therefore cannot be optimized directly with standard techniques. A key observation of this work is that its first variation corresponds to the expected marginal hypervolume contribution of a candidate, which yields a tractable adaptive reward via an unbiased estimator based on model samples. HVFT uses this reward to decompose the objective into a sequence of KL-proximal scalar-reward subproblems. We establish concavity, relative smoothness, and convergence guarantees for the resulting distributional procedure. Across therapeutic-peptide and molecular design tasks spanning discrete diffusion and continuous flow-matching models, HVFT achieves state-of-the-art expected hypervolume and trade-off coverage.

0.04

Elite-Weighted Supervised Fine-tuning for Goal-Directed Molecular Optimization

cs.LG ·2026-08-31 ·Shiyun Wa, Yifei Wang, Anna G. Green, Simone Sciabola, Ye Wang
benchmark similarity 0.65
Abstract

Goal-directed optimization is essential for steering molecular generators to propose candidates with desired properties. However, it is often implemented with policy-gradient reinforcement learning, which requires a generation-trajectory log-probability whose form depends on the model architecture and generation procedure. This makes an optimizer difficult to reuse across architectures and conditional generative designs. Supervised fine-tuning needs none of that machinery, but its update is driven by a fixed dataset, so the reward never enters the update. We introduce Elite-Weighted Supervised Fine-tuning (EW-SFT), which uses reward to guide elite selection of high-scoring molecules, and updates the model by its own pretraining loss on that set. Ablations show that reward information is passed primarily through elite selection, rather than through continuous weighting within the selected set. Because the update consumes only scored molecules and the model's native loss, the same rule applies across autoregressive, masked-diffusion, and discrete-flow generators, and across de novo, motif-extension, and linker-design tasks. Under a fixed budget of 3D shape alignment oracle calls on two kinase reference compounds, EW-SFT consistently outperforms the corresponding native optimizers. It further improves goal-directed optimization under a 2D similarity oracle on four held-out references and achieves comparable performance on a sample-efficiency benchmark without a trajectory-level RL formulation. These results demonstrate that EW-SFT is a unified and effective optimizer across molecular generators, design constraints, references, and oracles.

0.21

FAR-DPO: Feasibility-Aware and Robust Direct Preference Optimization for Cyclic Peptide Design

cs.LG ·2026-08-20 ·Guofeng Zhang, Rong Han, Xiaoyu Wang, Zhiyun Li, Zongbo Han +2 more
benchmarkhot direction similarity 0.64
Abstract · 8 pages, 4 figures, 3 tables. Accepted at the AIPBDA workshop of IEEE BIBM 2026

Cyclic peptides are emerging as promising molecular scaffolds in drug discovery due to their high binding affinity and structural stability. However, extending generative models from linear to cyclic peptide design remains challenging, as cyclization sharply restricts the feasible design space through coupled geometric and biophysical constraints. Moreover, limited training data has led existing approaches to rely largely on zero-shot generation or post hoc filtering, resulting in low yields of feasible designs and limited control over multi-objective trade-offs. To address these limitations, we propose FAR-DPO (Feasibility-Aware and Robust Direct Preference Optimization), an architecture-agnostic framework that steers generative models toward structurally and biophysically feasible cyclic peptide designs, particularly for challenging targets. FAR-DPO integrates feasibility-aware preference construction with difficulty-aware group-robust optimization. Specifically, it constructs within-target preference pairs through feasibility-gated multi-objective dominance and adaptively reweights predefined difficulty groups according to their current preference losses. Under a fixed generation budget, FAR-DPO increases overall success rate on the CPSea benchmark from 46.9% to 57.8% on PepGLAD and from 48.0% to 49.6% on PepFlow. These gains also extend to the hardest target quartile and are accompanied by more favorable best-per-target binding scores. Together, these results demonstrate FAR-DPO's effectiveness in improving feasibility and target-wise robustness.

0.38